Bradford Sgrignoli, DO
Retina Specialist · Harrisburg, PANPI 1003166000
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,190 of the $3,055 with a category attached, or 71.7%. 11 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 31.7% of the total.
Across 70 payments — averaging $43.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$969
- Notal Vision, Inc.$866
- Genentech USA, Inc.$508
- AbbVie$467
- Bausch & Lomb Americas Inc.$64
- Rxsight Inc$56
- plus $127 from 5 others
What the payments were for
- Speaking & faculty fees$86628%
- Food & beverage$2,19072%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 28 | $969 |
| Notal Vision, Inc. | 1 | $866 |
| Genentech USA, Inc. | 14 | $508 |
| AbbVie | 14 | $467 |
| Bausch & Lomb Americas Inc. | 4 | $64 |
| Rxsight Inc | 2 | $56 |
| Oyster Point Pharma, Inc. | 2 | $38 |
| Novartis | 2 | $35 |
| Johnson & Johnson Vision Care, Inc. | 1 | $22 |
| Aerie Pharmaceuticals, Inc. | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,055 in reported general payments places this provider in the 55th percentile of 43 retina specialist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 14 | $4,835 |
| Difluprednate | 24 | $4,499 |
| Brimonidine Tartrate | 29 | $3,900 |
| Prednisolone Acetate | 72 | $3,672 |
| Ketorolac Tromethamine | 84 | $1,929 |
| Latanoprost | 113 | $1,671 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 54 | $1,034 |
| Atropine Sulfate | 20 | $708 |
| Ofloxacin | 19 | $280 |
| Timolol Maleate | 27 | $234 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Harrisburg
- Joshua GreenePhiladelphia$394K
- Jay ChhablaniPittsburgh$70K
- Sachin PatelPottsville$17K
- Brian VanderbeekPhiladelphia$14K
- Thucanh MultererFogelsville$9K
- Christopher BairHermitage$9K
- Albert MaguirePhiladelphia$9K
- Hugo LinaresPhiladelphia$7K
- Moiz CarimWyomissing$6K
- Salman PorbandarwallaLancaster$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.